Progesterone receptor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: <StructureSection load='1p6o' size='350' side='right' caption='Structure of yeast cytosine deaminase complex with pyrimidine-based inhibitor, acetate, Ca+2 (green) and Zn+2 (grey) ions (PD...)
Current revision (09:29, 18 January 2024) (edit) (undo)
 
(15 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='1p6o' size='350' side='right' caption='Structure of yeast cytosine deaminase complex with pyrimidine-based inhibitor, acetate, Ca+2 (green) and Zn+2 (grey) ions (PDB entry [[1p6o]])' scene='55/551217/Cv/1'>
+
<StructureSection load='2w8y' size='350' side='right' caption='Structure of human progesterone receptor ligand-binding domain complex with RU486 and sulfate (PDB entry [[2w8y]])' scene='78/780972/Cv/2'>
-
 
+
-
<ref>PMID:21638687</ref>
+
== Function ==
== Function ==
-
== Disease ==
+
'''Progesterone receptor''' (PR) binds to DNA and inhibits transcription. It is [[Nuclear receptors|nuclear receptor]]. The inhibition terminates when progesterone binds to PR. The ovarian steroid progesterone which is essential for breast development and reproductive behavior, is mediated by PR<ref>PMID:19072517</ref>.
 +
 
 +
See also [[Intracellular receptors]]
== Relevance ==
== Relevance ==
 +
 +
The response to hormone therapy in breast cancer correlates with PR. PR absence in breast tumor cells predicts resistance to hormone therapy <ref>PMID:16234531</ref>. [[Mometasone]] is a potent agonist of PR<ref>PMID:15189034</ref>.
== Structural highlights ==
== Structural highlights ==
-
 
+
The structure of the complex of the ligand-binding domain of PR with RU486 - an abortion-inducing drug - shows the ligand bound at a similar location to other agonists or partial agonists with a flexible loop of PR being a possible entry route to the <scene name='78/780972/Cv/4'>binding site and several PR-RU486 interactions</scene><ref>PMID:19372222</ref>. Water molecules are shown as red spheres. <scene name='89/895670/Cv/8'>Human progesterone receptor ligand-binding domain bound with progesterone</scene> ([[1a28]]).
</StructureSection>
</StructureSection>
== 3D Structures of progesterone receptor ==
== 3D Structures of progesterone receptor ==
Line 17: Line 19:
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
{{#tree:id=OrganizedByTopic|openlevels=0|
{{#tree:id=OrganizedByTopic|openlevels=0|
 +
 +
* Progesterone receptor residues 1-125
 +
 +
**[[1ejf]] – hPR - human<br />
 +
 +
* Progesterone receptor residues 72-195
 +
 +
**[[4x8y]] – hPR<br />
* Progesterone receptor DNA-binding domain residues 399-476
* Progesterone receptor DNA-binding domain residues 399-476
-
**[[2c7a]] – hPR DBD + DNA - human<br />
+
**[[2c7a]] – hPR DBD + DNA<br />
* Progesterone receptor ligand-binding domain residues 673-933
* Progesterone receptor ligand-binding domain residues 673-933

Current revision

Structure of human progesterone receptor ligand-binding domain complex with RU486 and sulfate (PDB entry 2w8y)

Drag the structure with the mouse to rotate

3D Structures of progesterone receptor

Updated on 18-January-2024

References

  1. Lange CA, Yee D. Progesterone and breast cancer. Womens Health (Lond). 2008 Mar;4(2):151-62. doi: 10.2217/17455057.4.2.151. PMID:19072517 doi:http://dx.doi.org/10.2217/17455057.4.2.151
  2. Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol. 2005 Oct 20;23(30):7721-35. doi: 10.1200/JCO.2005.09.004. PMID:16234531 doi:http://dx.doi.org/10.1200/JCO.2005.09.004
  3. Madauss KP, Deng SJ, Austin RJ, Lambert MH, McLay I, Pritchard J, Short SA, Stewart EL, Uings IJ, Williams SP. Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes. J Med Chem. 2004 Jun 17;47(13):3381-7. PMID:15189034 doi:http://dx.doi.org/10.1021/jm030640n
  4. Raaijmakers HC, Versteegh JE, Uitdehaag JC. The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation. J Biol Chem. 2009 Jul 17;284(29):19572-9. Epub 2009 Apr 16. PMID:19372222 doi:http://dx.doi.org/10.1074/jbc.M109.007872

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Personal tools